Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.

Cochrane database of systematic reviews (Online)

Volumn 4, Issue , 2011, Pages

  Shelley, Mike ^a   Cleves, Anne ^b   Wilt, Timothy J ^b   Mason, Malcolm ^b  

^a Velindre NHS Trust   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CARBOPLATIN; CISPLATIN; DEOXYCYTIDINE; DOXORUBICIN; DRUG DERIVATIVE; GEMCITABINE; METHOTREXATE; PACLITAXEL; VINBLASTINE;

BLADDER TUMOR; HUMAN; META ANALYSIS; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRANSITIONAL CELL CARCINOMA;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; DEOXYCYTIDINE; DOXORUBICIN; HUMANS; METHOTREXATE; PACLITAXEL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 79955688287     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: None     Document Type: Review

References (0)